The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization

Molecular Vision

Volumn 19, Issue , 2013, Pages 1293-1303

  Peng, Wenyan ^a,c   Yu, Ying ^a   Li, Tiejun ^b   Zhu, Yuanyuan ^b   Chen, Hui ^a  

^a NANTONG UNIVERSITY   (China)

^b Biomics Biotechnologies Co Ltd   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; SMALL INTERFERING RNA; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NEOVASCULARIZATION (PATHOLOGY); PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; WOUND HEALING; BIOLOGICAL MODEL; CELL MOTION; CELL SURVIVAL; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE SILENCING; METABOLISM;

CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, SMALL INTERFERING; THROMBOPLASTIN; TRANSFECTION;

EID: 84879173057     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies. Surv Ophthalmol 2003; 48:257-293. [PMID: 12745003].
2. Oh H. A Novel Molecular Mechanism Involving Neuropilin-1 for Vascular Endothelial Growth Factor-induced Retinal Angiogenesis. Jpn J Ophthalmol 2004; 48:309.
3. Booij JC, Baas DC, Beisekeeva J, Gorgels TG, Bergen AA. The dynamic nature of Bruch's membrane. Prog Retin Eye Res 2010; 29:1-18. [PMID: 19747980].
4. Campa C, Costagliola C, Incorvaia C, Sheridan C, Semeraro F, De Nadai K, Sebastiani A, Parmeggiani F. Inflammatory mediators and angiogenic factors in choroidal neovascu-larization: pathogenetic interactions and therapeutic implications. Mediators Inflamm 2010; 2010:xx-xx. [PMID: 20871825].
5. Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovasculariza-tion. Invest Ophthalmol Vis Sci 2000; 41:3158-3164. [PMID: 10967078].
6. Witmer AN. Vascular endothelial growth factors and angio-genesis in eye disease. Prog Retin Eye Res 2003; 22:1-29. [PMID: 12597922].
7. West SK. Looking forward to 20/20: a focus on the epide-miology of eye diseases. Epidemiol Rev 2000; 22:64-70. [PMID: 10939008].
8. Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, PaulusTVM-deJong. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997; 81:154-162. [PMID: 9059252].
9. Baff J, Byrnes G, Chan C-C, Csaky KG. Choroidal neovas-cularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 2000; 41:3582-3589. [PMID: 110 0 62 56].
10. Wang F. AAV-Mediated Expression of Vascular Endothelial Growth Factor Induces Choroidal Neovascularization in Rat. Invest Ophthalmol Vis Sci 2003; 44:781-790. [PMID: I2 55 6 414].
11. Lebherz C, Maguire AM, Auricchio A, Tang W, Aleman TS, Wei Z, Grant R, Cideciyan AV, Jacobson SG, Wilson JM, Bennett J. Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor. Diabetes 2005; 5 4:1141-1149. [PMID: 15793254].
12. Ryan SJ. Subretinal neovascularization: natural history of an experimental model. Arch Ophthalmol 1982; 100:1804-1809. [PMID: 6182868].
13. Yi X, Ogata N, Komada M, Yamamoto C, Takahashi K, Omori K, Uyama M. Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 1997; 235:313-319. [PMID: 9176680].
14. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovasculariza-tion in a mouse model. Mol Vis 2003; 9:210-216. [PMID: 12789138].
15. Gu L, Chen H, Tuo J, Gao X, Chen L. Inhibition of experi-mental choroidal neovascularization in mice by anti-VEGFA/ VEGFR2 or non-specific siRNA. Exp Eye Res 2010; 91:433-439. [PMID: 20599960].
16. Rosenfeld PJ, Schwartz SD, Blumenkranz MS, Miller JW, Haller JA, Reimann JD, Greene WL, Shams N. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 2005; II2: 1048-1053. [PMID: 15885778].
17. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355:1419-1431. [PMID: 17 0 21318].
18. Emerson MV, Lauer AK. Emerging therapies for the treat-ment of neovascular age-related macular degeneration and diabetic macular edema. BioDrugs 2007; 21:245-257. [PMID: 1762 81 2 2].
19. Chappelow AV, Kaiser PK. Neovascular age-related macular degeneration: potential therapies. Drugs 2008; 68:1029-1036. [PMID: 18484796].
20. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000; 97:10242-10247. [PMID: 10963684].
21. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. J Mol Neurosci 2000; 14:197-203. [PMID: 10 984196].
22. Böcker-Meffert S, Rosenstiel P, Rohl C, Warneke N, Held-Feindt J, Sievers J, Lucius R. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest Ophthalmol Vis Sci 2002; 43:2021-2026. [PMID: 12 0 37014].
23. Mackenzie F, Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development 2012; 139:1371-1380. [PMID: 22434866].
24. Cho Y, Cao X, Shen D, Tuo J, Parver LM, Rickles FR, Chan CC. Evidence for enhanced tissue factor expression in age-related macular degeneration. Lab Invest 2011; 91:519-526. [PMID: 210 42291].
25. Cho Y, Rickles FR, Parver LM, Tuo J, Chan C-C. The potential pathophysiological role of tissue factor in age-related macular degeneration. Expert Rev Ophthalmol 2010; 5:27-34.
26. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C, Elner VM, Elner SG, Sternberg P Jr. Macro-phage and retinal pigment epithelium expression of angio-genic cytokines in choroidal neovascularization. Mol Vis 2002; 8:119-126. [PMID: 119 79 2 37].
27. Chu AJ. Tissue factor mediates inflammation. Arch Biochem Biophys 2005; 440:123-132. [PMID: 16036212].
28. Chu AJ. Tissue factor upregulation drives a thrombosis- inflammation circuit in relation to cardiovascular complications. Cell Biochem Funct 2006; 24:173-192. [PMID: 156170 2 4].
29. Hu Z, Sun Y, Garen A. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proc Natl Acad Sci USA 1999; 9 6:8161-8166. [PMID: 10393965].
30. Hu Z, Garen A. Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy. Proc Natl Acad Sci USA 2000; 97:9221-9225. [PMID: 10922073].
31. Hu Z, Garen A. Targeting tissue factor on tumor vascular endo-thelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci USA 2001; 9 8:1 2180-2185. [PMID: 115 9 3 0 3 4].
32. Bora PS, Hu Z, Tezel TH, Sohn JH, Kang SG, Cruz JM, Bora NS, Garen A, Kaplan HJ. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc Natl Acad Sci USA 2003; 100:2679-2684. [PMID: 12589025].
33. Tezel TH, Bodek E, Sonmez K, Kaliappan S, Kaplan HJ, Hu Z, Garen A. Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody. Ocul Immunol Inflamm 2007; 15:3-10. [PMID: 17 3658 0 0].
34. Wang B, Chen YB, Ayalon O, Bender J, Garen A. Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement. Proc Natl Acad Sci USA 1999; 96:1627-1632. [PMID: 9990075].
35. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004; 431:371-378. [PMID: 15372045].
36. Xu C, Gui Q, Chen W, Wu L, Sun W, Zhang N, Xu Q, Wang J, Fu X. Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. Journal of experimental & clinical cancer research CR (East Lansing, Mich) 2011; 30:63.
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25:402-408. [PMID: 11846609].
38. Yeh CH, Peng H-C, Huang T-F. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as inte-grin alpha v beta-antagonist and inducing apoptosis. Blood 1998; 92:3268-276. [PMID: 9 787163].
39. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res 2003; 9:5339-5345. [PMID: 14614 019].
40. Folkman J. Tumor angiogenesis and tissue factor. Nat Med 1996; 2:167-168. [PMID: 8574960].
41. Rickles FR, Shoji M, Abe K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int J Hematol 2001; 73:145-150. [PMID: 11372724].
42. Ji M, Yi S, Yu D, Wang W. SiRNA-mediated tissue factor knockdown in porcine neonatal islet cell clusters in vitro. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011; 36:1141-1146. [PMID: 22246358].
43. Li H, Tian ML, Yu G, Liu YC, Wang X, Zhang J, Ji SQ, Zhu J, Wan YL, Tang JQ. Hyperthermia synergizes with tissue factor knockdown to suppress the growth and hepatic metastasis of colorectal cancer in orthotopic tumor model. J Surg Oncol 2012; 106:689-695. [PMID: 22532129].
44. Miller JW, Adamis AP, Aiello LP. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 1997; 13:37-50. [PMID: 9134347].
45. Vert JP, Foveau N, Lajaunie C, Vandenbrouck Y. An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics 2006; 7:520. [PMID: 1713749 7].